Total Payments
$342.27
2024 Payments
$323.18
Companies
11
Transactions
18
Medicare Patients
1,672
Medicare Billing
$106,561
Payment Breakdown by Category
Food & Beverage$342.27 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $342.27 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $85.56 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $47.14 | 2 | $0 (2024) |
| Corium, LLC | $42.75 | 2 | $0 (2024) |
| Novo Nordisk Inc | $31.70 | 2 | $0 (2024) |
| Amgen Inc. | $31.18 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $20.13 | 1 | $0 (2024) |
| Genentech USA, Inc. | $19.09 | 1 | $0 (2019) |
| Exact Sciences Corporation | $18.61 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $16.07 | 1 | $0 (2024) |
| Lilly USA, LLC | $15.72 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.18 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($85.56) |
| 2019 | $19.09 | 1 | Genentech USA, Inc. ($19.09) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Bone Health | ||||||
| 09/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/13/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ANTIBIOTIC | ||||||
| 08/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 05/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 02/26/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 370 | 412 | $78,485 | $26,376 |
| 2022 | 9 | 414 | 444 | $76,783 | $29,223 |
| 2021 | 12 | 559 | 735 | $100,218 | $35,750 |
| 2020 | 6 | 329 | 349 | $66,019 | $15,212 |
Total Patients
1,672
Total Services
1,940
Medicare Billing
$106,561
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 146 | 146 | $35,040 | $11,025 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 127 | $30,480 | $10,926 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $6,075 | $1,692 | 27.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 27 | 27 | $2,160 | $1,095 | 50.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 28 | 58 | $2,900 | $940.76 | 32.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 16 | $1,280 | $519.30 | 40.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $550.00 | $178.20 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $17,400 | $7,542 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 58 | $13,920 | $6,137 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 75 | 75 | $18,000 | $5,921 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 67 | $15,075 | $4,702 | 31.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 87 | 90 | $7,200 | $3,846 | 53.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 20 | 40 | $2,000 | $655.00 | 32.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 13 | $650.00 | $211.90 | 32.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 12 | $1,608 | $138.94 | 8.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 29 | 31 | $930.00 | $68.92 | 7.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 156 | 156 | $37,440 | $12,465 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 109 | $24,525 | $7,045 | 28.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $12,900 | $6,410 | 49.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 100 | 104 | $8,240 | $4,659 | 56.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 27 | $6,480 | $3,055 | 47.1% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $2,475 | $843.81 | 34.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 14 | 14 | $1,582 | $369.46 | 23.4% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 19 | 19 | $950.00 | $314.07 | 33.1% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 14 | 14 | $1,876 | $289.30 | 15.4% |
About Dr. Richard Boone, DO
Dr. Richard Boone, DO is a Family Medicine healthcare provider based in Vienna, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023080215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Boone, DO has received a total of $342.27 in payments from pharmaceutical and medical device companies, with $323.18 received in 2024. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($342.27).
As a Medicare-enrolled provider, Boone has provided services to 1,672 Medicare beneficiaries, totaling 1,940 services with total Medicare billing of $106,561. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Vienna, WV
- Active Since 02/02/2006
- Last Updated 12/18/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023080215
Products in Payments
- XIFAXAN (Drug) $85.56
- TRELEGY ELLIPTA (Drug) $47.14
- Azstarys (Drug) $42.75
- VOQUEZNA (Drug) $20.13
- Xofluza (Drug) $19.09
- Cologuard Collection Kit (Device) $18.61
- Ozempic (Drug) $16.64
- FARXIGA (Drug) $16.07
- MOUNJARO (Drug) $15.72
- EVENITY (Biological) $15.63
- Repatha (Biological) $15.55
- Rybelsus (Drug) $15.06
- NUZYRA (Drug) $14.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vienna
Zaid Khalil, M.d, M.D
Family Medicine — Payments: $18,527
Family Medicine $18,527
Dr. Barbara Mackie, Md, MD
Family Medicine — Payments: $10,097
Family Medicine $10,097
Dr. Daniel Fitzpatrick, D.o, D.O
Family Medicine — Payments: $8,014
Family Medicine $8,014
Dr. Barnett Mennen, M.d, M.D
Family Medicine — Payments: $4,521
Family Medicine $4,521
Ernest Miller, Do, DO
Family Medicine — Payments: $4,057
Family Medicine $4,057
Dr. Daniel Merenstein, Md, MD
Family Medicine — Payments: $3,041
Family Medicine $3,041